Pulsenmore

Pulsenmore OCF Margin

The Operating Cash Flow Margin of Pulsenmore (PLSM.TA) as of Nov 21, 2026 is -82.14 %. In the previous year, Operating Cash Flow Margin was -349.76 % — a change of -76.51% (higher).

OCF Margin

-82.14 %

YoY

-76.51%

Last updated:

Operating Cash Flow Margin of Pulsenmore is 2025 -82.14 % . Operating Cash Flow Margin of Pulsenmore was 2024 -349.76 % . It decreases by -76.51% higher compared to the previous year.

The Pulsenmore OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2021
-1,649.62 ILS
Jan 1, 2022
-231.37 ILS
Jan 1, 2023
-691.84 ILS
Jan 1, 2024
-349.76 ILS
Jan 1, 2025
-82.14 ILS
The Pulsenmore OCF Margin history
YEAROCF MarginYoY
-82.14 %-76.51%
-349.76 %-49.45%
-691.84 %+199.02%
-231.37 %-85.97%
-1,649.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulsenmore Stock analysis

What does Pulsenmore do? Pulsenmore Ltd. generates revenue through the sale of its two miniaturized ultrasound systems, PulseNmore ES and PulseNmore FC, designed for home use in remote clinical diagnosis. The PulseNmore ES targets pregnant women requiring regular ultrasound monitoring, while PulseNmore FC caters to women undergoing in vitro fertilization needing follicle size assessments. Both systems integrate with smartphones, enabling patients to conduct tests at home and share results online with healthcare providers. The company also monetizes through software delivery for its devices, enhancing user experience and data management. The primary buyers of PulseNmore ES are pregnant women seeking convenient, clinic-free monitoring, and healthcare providers managing prenatal care remotely. PulseNmore FC is purchased by women undergoing in vitro fertilization, often through fertility clinics or medical centers that recommend the device. These segments value the convenience of home-based diagnostics and seamless telehealth integration without requiring in-person visits. Pulsenmore Ltd. focuses on global markets for its portable ultrasound solutions, serving patients in remote or underserved areas who benefit from telehealth-enabled diagnostics. The company’s products are positioned as cost-effective alternatives to traditional clinic visits, appealing to both end-users and healthcare institutions aiming to reduce operational costs while maintaining patient care quality. Pulsenmore is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulsenmore stock

Operating Cash Flow Margin of Pulsenmore is -82.14 % in 2025.

Operating Cash Flow Margin of Pulsenmore changed from -349.76 % to -82.14 %, representing a -76.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Pulsenmore since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Pulsenmore with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Pulsenmore

All Key Metrics — Pulsenmore